Press Room

Oral and Inhalation Solid Dosage Forms Workshop

Start
Wednesday, March 27, 2019 - 00:00
End
Wednesday, March 27, 2019 - 00:00
Location: Switzerland
Oral Inhalation nasal Solid Dosage Forms | Hovione

 

Hovione is present at the Oral and Inhalation Solid Dosage Forms Workshop with a presentation by Maria Braga, Scientist of R&D Drug Product Development.

The workshop, organised at the MG2 premises on March Wednesday 27th, gives delegates the possibility to meet different industrial partners in a real market place; a place in which Academy and Industry can share their experiences and knowledge.



This event will last one day, divided in 2 different moments: speeches in the morning and workshop in the afternoon at MG2 Factory.

 

HOVIONE PRESENTATION

Title: From the engineered particle to lung deposition: how to successfully develop a carrier-based DPI?

Time: 9:30 am

Presenter: Maria Braga, Scientist of R&D Drug Product Development

 

 

If you would like to find more about Hovione's full range of inhalation drug development servicesparticle engineering and development by design schedule a meeting with us

Schedule a meeting button | Hovione

 

 

 

 

 

Also in the Press Room

See All

In an interview with Executiva, a portuguese media outlet focused on women´s leadership, Diane Villax, co-founder and long-standing leader of Hovione, reflects on her journey and the company’s development over more than six decades. Diane Villax’s career began at a time when few women worked outside the home. At 19, she joined a trading company as a foreign languages correspondent, where she developed essential business skills — including commercial correspondence, banking and export procedures — that later proved instrumental in helping her husband, Ivan Villax, establish Hovione in 1959. From its earliest days operating in the family home in Lisbon, Hovione adopted an international outlook. The company’s first major customers were in Japan, setting demanding quality standards that helped shape its long-term position in global markets. Over the following decades, Hovione expanded its footprint with the construction of its first manufacturing site in Loures (1969), followed by expansion to Macau (1986), the United States (New Jersey, early 2000s) and Ireland (Cork). The company grew into a global organization with more than 2,500 employees — including over 300 scientists — and a reputation as a preferred supplier to leading pharmaceutical companies worldwide. Throughout the interview, Diane highlights the values that have guided the company’s development: a commitment to excellence, a strong work ethic, and a focus on quality and long-term relationships. Although she did not have formal business training, she learned “on the job” and brought discipline, precision and structure to her role — particularly in the company’s early financial and administrative leadership. Now in her nineties and an active member of Hovione’s Board of Directors, Diane Villax remains engaged with the company’s evolution and governance, reflecting a continued commitment to its long-term development. Her story reflects entrepreneurial drive, resilience and long-term leadership — and offers insight into the values that have shaped Hovione’s trajectory for more than six decades. Read the full interview at Executiva.pt (in portuguese).    

Article

Hovione’s Diane Villax: “I was not brought up to be a business woman”

Feb 23, 2026